Medications for Tremor Treatment

Essential Tremor Treatment

The American Academy of Neurology recommends propranolol or primidone as first-line treatment for essential tremor, which are effective in up to 70% of patients 1, 2
Propranolol is the most established medication for essential tremor, having been used for over 40 years with demonstrated efficacy 3, 4, 5
Primidone is another first-line option for essential tremor 1
Medications for essential tremor are only initiated when tremor symptoms interfere with function or quality of life 1, 2
Carbamazepine may be used as a second-line therapy for essential tremor, though it's generally not as effective as first-line therapies 1

Parkinson's Disease Tremor Treatment

No relevant cited facts available for this section

Treatment Selection Considerations

Beta-blockers, such as propranolol, should be avoided in patients with chronic obstructive pulmonary disease, bradycardia, or congestive heart failure 1, 6, 7
Beta-blockers may cause adverse effects including lethargy and depression, dizziness and hypotension, and exercise intolerance and sleep disorders 7
In elderly patients, excessive heart rate reduction with beta-blockers may lead to serious adverse events 4
For patients with both essential tremor and hypertension, beta-blockers may provide dual benefits 4, 5

Surgical Options for Refractory Tremor

Surgical therapies, such as deep brain stimulation (DBS) or magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy, may be considered when medications fail due to lack of efficacy, side effects, or contraindications 1, 2, 6, 8
MRgFUS thalamotomy has shown sustained tremor improvement of 56% at 4 years 1, 6, 8
Radiofrequency thalamotomy is another surgical option for refractory tremor 6, 9

Monitoring and Follow-up

Regular assessment of tremor severity and medication side effects is essential 7
Dose adjustments may be needed based on clinical response and tolerability 1
If first-line agents fail, consider switching to or adding second-line medications before considering surgical options 1, 2

Surgical Interventions for Essential Tremor

Indications for Surgical Therapy

Surgical therapies should be considered when medications fail due to lack of efficacy at maximum doses, dose-limiting side effects, medical contraindications, or occupational limitations 10

Magnetic Resonance-Guided Focused Ultrasound Thalamotomy

Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy shows sustained tremor improvement of 56% at 4 years 10
MRgFUS thalamotomy has a lower complication rate (4.4%) compared to radiofrequency thalamotomy (11.8%) and DBS (21.1%) 10
MRgFUS thalamotomy is contraindicated bilaterally or contralateral to a previous thalamotomy 11
MRgFUS thalamotomy requires a skull density ratio ≥0.40 11
MRgFUS thalamotomy cannot be used in patients unable to undergo MRI 11

Treatment Algorithm for Medically Refractory Tremor

For medically refractory tremor causing significant disability, consider surgical options, including MRgFUS thalamotomy for unilateral tremor or patients with medical comorbidities 10

Medications for Treating Tremors

Beta-Blockers for Tremor Management

The American Heart Association recommends propranolol as a first-line treatment for essential tremor, with a dosage range of 80-240 mg/day, as it has been shown to be effective in managing tremors 12
The American College of Cardiology suggests that nadolol, an alternative beta-blocker, has evidence for tremor control at a dosage of 40-320 mg daily 13
Metoprolol may be effective for tremor management at a dosage of 25-100 mg extended release daily or twice daily, according to the American Heart Association 13
Atenolol has limited evidence for moderate effect in tremor management, with common adverse effects including fatigue, depression, nausea, dizziness, and insomnia 12
Timolol has been shown to be effective in tremor control at a dosage of 20-30 mg/day, as reported by the American College of Cardiology 12
Beta-blockers, such as propranolol, can cause common adverse effects including fatigue, depression, nausea, dizziness, and insomnia, as well as cold extremities and bronchospasm 12, 13

Second-Line Medications for Essential Tremor

Gabapentin has limited evidence for moderate efficacy in tremor management, according to the American Academy of Neurology 14

Deep Brain Stimulation for Essential Tremor

Patient Eligibility Assessment

The American Academy of Neurology recommends that patients with essential tremor have no dementia or severe depression, and sufficient residual motor function to expect improvement following surgery, as evidenced by this patient's neuropsych evaluation showing depression "under control" and no focal lesions of the basal ganglia, with sufficient residual motor function 15
Patients with essential tremor should have a confirmed diagnosis, failed treatment with first-line medications, and tremor significantly affecting activities of daily living, with this patient meeting these criteria 15

Surgical Options for Medication-Refractory Essential Tremor

The American Society for Stereotactic and Functional Neurosurgery suggests that DBS implantation typically requires inpatient admission, as opposed to ambulatory procedures, due to the need for careful monitoring in the immediate post-operative period for potential complications 15

Deep Brain Stimulation for Essential Tremor

Patient Eligibility and Medical Necessity

The American Academy of Neurology recommends that patients with essential tremor should have no cerebral atrophy or focal lesions of the basal ganglia, as shown by MRI, to be eligible for deep brain stimulation (DBS) 16
Patients with essential tremor who have failed first-line medication therapy, such as primidone, which is only effective in up to 70% of patients, may be considered for DBS 16

Surgical Approach and Expected Outcomes

The International Parkinson and Movement Disorder Society suggests that the ventral intermediate nucleus (VIM) of the thalamus is the established target for DBS in essential tremor, and left-sided stimulation is appropriate for unilateral treatment targeting the dominant hand tremor 17
The awake procedure allows for intraoperative testing to confirm optimal electrode placement and immediate tremor control, as recommended by the Congress of Neurological Surgeons 18

Alternative Treatments

The American Society for Stereotactic and Functional Neurosurgery reports that magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy shows lower complication rates (4.4%) compared to DBS (21.1%), but has specific contraindications 17
The society also notes that radiofrequency thalamotomy carries higher complication risks (11.8%) compared to MRgFUS, and DBS may be a more suitable option for some patients 17, 16

Treatment Options for Tremors

Non-Pharmacological Approaches

Rhythm modification techniques can help control tremor, including superimposing alternative rhythms on existing tremor and gradually slowing movement to complete rest, as recommended by the Journal of Neurology, Neurosurgery and Psychiatry 19
For unilateral tremor, using the unaffected limb to dictate a new rhythm can help entrain the tremor to stillness, according to the Journal of Neurology, Neurosurgery and Psychiatry 19
Using gross rather than fine movements can be helpful, especially for activities like handwriting, as suggested by the Journal of Neurology, Neurosurgery and Psychiatry 19
Avoiding cocontraction or tensing of muscles as this is unlikely to be a helpful long-term strategy, as stated by the Journal of Neurology, Neurosurgery and Psychiatry 19

Surgical Options for Refractory Tremor

Surgical therapies should be considered when medical therapies fail due to lack of efficacy at maximum doses, as recommended by Neurosurgery 20
MRgFUS thalamotomy has a lower complication rate (4.4%) compared to radiofrequency thalamotomy (11.8%) and deep brain stimulation (DBS) (21.1%), according to Neurosurgery 20
MRgFUS is contraindicated in patients who cannot undergo MRI, have skull density ratio <0.40, or need bilateral treatment, as noted by Neurosurgery 20

Important Considerations and Pitfalls

Avoid prescribing aids and equipment for functional tremor in the acute phase, as they may interrupt normal automatic movement patterns, as advised by the Journal of Neurology, Neurosurgery and Psychiatry 19
If aids are necessary for safety, they should be considered short-term solutions with a plan to progress toward independence, according to the Journal of Neurology, Neurosurgery and Psychiatry 19

Essential Tremor Treatment Options

Surgical Options for Medication-Refractory Essential Tremor

MRgFUS thalamotomy shows sustained tremor improvement of 56% at 4 years, with a lower complication rate (4.4%) compared to radiofrequency thalamotomy (11.8%) and deep brain stimulation (DBS) (21.1%) 21
MRgFUS has early adverse effects including gait disturbance (36%) and paresthesias (38%), which decrease to 9% and 14% respectively by 1 year 21
Serious adverse events with MRgFUS are rare (1.6%), with most adverse events being mild or moderate (98.4%) and more than 50% resolving by 1 year 21
MRgFUS is contraindicated in patients who cannot undergo MRI, patients with skull density ratio <0.40, and is not indicated for bilateral treatment or contralateral to a previous thalamotomy 21
Radiofrequency thalamotomy is available but carries higher complication risks than MRgFUS 21

Treatment Algorithm

For medication-refractory tremor, consider surgical options based on patient characteristics, with MRgFUS thalamotomy preferred due to lower complication rates 21
For unilateral tremor or patients with medical comorbidities, MRgFUS thalamotomy is preferred due to lower complication rates 21
For bilateral tremor or patients with contraindications to MRgFUS, consider DBS 21

Deep Brain Stimulation for Essential Tremor

Patient Selection and Treatment Options

The American Academy of Neurology recommends DBS as a treatment option for patients with essential tremor who are relatively young, as it offers an adjustable treatment option 22, 23
DBS is preferred over MRgFUS for patients with bilateral tremor involvement, as MRgFUS is not indicated for bilateral treatment 24, 25
The International Parkinson and Movement Disorder Society notes that DBS provides adjustable, reversible tremor control that can be optimized over time, making it a suitable option for patients with severe tremor 24, 25

Risks and Considerations

The American Society for Stereotactic and Functional Neurosurgery reports that MRgFUS thalamotomy is associated with risks such as dysarthria and dysgeusia 24
The society also notes that MRgFUS has limitations, including the inability to adjust or reverse effects if complications occur 25

Primidone for Essential Tremor: Efficacy and Side Effects

Mechanism and Efficacy

Therapeutic benefit from primidone can occur even when derived phenobarbital levels remain subtherapeutic, confirming that primidone itself has anti-tremor properties 26
Clinical benefits may not become apparent for 2-3 months, so an adequate trial period is essential 27

Side Effects and Precautions

Behavioral disturbances, irritability, and sleep disturbances can occur, particularly at higher doses 26
Women of childbearing age should be counseled about teratogenic risks (neural tube defects) 27

Treatment Options for Essential Tremor

Introduction to Essential Tremor Treatment

Beta-blockers can cause bronchospasm in asthmatic patients, according to the Journal of Allergy and Clinical Immunology 28

Considerations for Patients with Asthma

The American Academy of Allergy, Asthma, and Immunology recommends avoiding beta-blockers, such as propranolol, in patients with asthma or chronic obstructive pulmonary disease (COPD) due to the risk of bronchospasm 28

Management of Essential Tremor with Beta-Blockers

Contraindications and Precautions

The European Heart Journal guidelines state that propranolol is contraindicated in patients with asthma, COPD, decompensated heart failure, second- or third-degree heart block, sick sinus syndrome without pacemaker, and sinus bradycardia (<50 bpm) 29
The European Heart Journal recommends avoiding propranolol in patients with respiratory disease due to the risk of bronchospasm 29
The European Heart Journal notes that propranolol may cause dizziness, hypotension, and bronchospasm, and recommends monitoring patients for these side effects 29

Treatment of Essential Tremor in Patients with Heart Failure

The European Heart Journal guidelines suggest that propranolol may be used cautiously in patients with compensated heart failure, but should be avoided in patients with decompensated heart failure 29
The European Heart Journal recommends monitoring patients with heart failure closely for worsening symptoms if propranolol is used 29